@article{d01fbf8151d94378bd7b904770b806cc,
title = "A New Treatment Strategy for Saphenous Vein Graft Lesions?: Letting it Go ∗",
keywords = "coronary artery bypass graft surgery, native coronary artery, percutaneous coronary intervention, saphenous vein graft",
author = "Brilakis, {Emmanouil S.} and Subhash Banerjee and Burke, {M. Nicholas}",
note = "Funding Information: Dr. Brilakis has received consulting/speaker honoraria from Abbott Vascular, ACIST, Amgen, Asahi, CSI, Elsevier, GE Healthcare, Medicure, Medtronic, and Nitiloop; has received research support from Boston Scientific and Osprey; has served on the board of directors of Cardiovascular Innovations Foundation; and has served on the board of trustees of the Society of Cardiovascular Angiography and Interventions. Dr. Banerjee has received research grants from Gilead and The Medicines Company; institutional research grants from Abbott Vascular and Boston Scientific; honoraria from Gore, Janssen, and Medtronic; consultant/speaker honoraria from Covidien and Medtronic; has intellectual property in HygeiaTel; and his spouse has ownership in MDCARE Global. Dr. Burke has received consulting and speaking honoraria from Abbott Vascular and Boston Scientific. ",
year = "2018",
month = may,
day = "8",
doi = "10.1016/j.jacc.2018.03.457",
language = "English (US)",
volume = "71",
pages = "1983--1985",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "18",
}